DHA Enterprise-Wide Commercial Solutions Opening (CSO)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Health Agency (DHA) has established the Enterprise-Wide Commercial Solutions Opening (CSO), solicitation number HT003826SC005, to identify and acquire commercial products, services, and non-developmental items. Active from August 7, 2026, through August 6, 2027, this initiative seeks commercially available capabilities that can be deployed immediately or modified to meet DHA requirements across its Medical Digital Solutions, Medical Services, and Medical Products portfolios. The government will utilize a variety of award vehicles, including firm-fixed-price FAR-based contracts and Other Transaction (OT) agreements for research, prototyping, and experimental purposes under authorities such as 10 U.S.C. 3458, 3201, 4021, 4022, and 4023. The procurement process is driven by the issuance of specific Areas of Interest (AoI), which define problem statements, objectives, and submission criteria. Submissions undergo a streamlined, multi-phase evaluation process: Phase I involves a pitch or white paper evaluated on a Go/No-Go basis for strategic alignment and feasibility; Phase II may include an optional oral presentation or demonstration to assess technical viability; and Phase III requires a full commercial proposal evaluated on technical merit, cost reasonableness, and past performance. This CSO is administered by the DHACA Defense Healthcare Management Systems Contracting Division and is designed to prioritize cost-effective, commercially viable solutions to enhance healthcare readiness and patient safety.
General Info
Place of Performance
Falls Church, VA, 22042, USASet-Aside
Timeline
Organization & Contact Information
Full Description
This announcement establishes the general competitive procedures the Government will utilize to award FAR-based contracts pursuant to 10 U.S.C. § 3201 and 10 U.S.C. § 3458, as amended, other transaction authority agreements pursuant to 10 U.S.C. §§ 4021 and 4022, to include but not limited to basic, applied, and advanced research projects, prototyping and production agreements, and procurements for experimental purposes (pursuant to 10 U.S.C. § 4023, as amended) to deliver commercial solutions pertaining to the General Scope of this CSO (pursuant to 10 U.S.C. § 3458).
The primary purpose of this CSO is to solicit proposals for commercial solutions comprising commercial products, commercial services, and non-developmental items pursuant to 10 U.S.C. § 3458, as amended by Section 1823 of the National Defense Authorization Act for Fiscal Year 2026. Proposed solutions must represent commercially available capabilities, or commercially available capabilities that can be modified to meet DHA’s requirements.
The Government will issue Areas of Interests (AoI) seeking submissions under this CSO. The Government may post new, extend, or revise AoIs at any time. Individual AoIs shall contain, at a minimum, the authority under which it is being solicited, a problem statement or desired objectives, evaluation or review criteria, proposal or solution submission criteria, and anticipated time to award.
This CSO will remain open until August 6, 2027 unless amended by the issuing office.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Health Agency (dha)
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS